01 2AbbVie Corporation
02 2Allergan Inc.
03 1Alcon Canada Inc.
04 1Gowling WLG (Canada) LLP
01 12080223
02 12173974
03 12225626
04 12310230
05 12357014
06 12440764
01 4Brimonidine Tartrate | Timolol
02 2Brinzolamide | Timolol Maleate
01 4Ophthalmic Solution
02 2suspension
01 12011-04-03
02 12014-09-19
03 12016-06-17
04 12018-11-05
05 12020-01-04
06 12023-04-09
Patent Expiration Date : 2023-04-09
Date Granted : 2005-10-25
Brimonidine Tartrate, Timolol Maleate
Brand Name : COMBIGAN
Patent Number : 2440764
Filing Date : 2003-04-09
Strength per Unit : 0.2% / 0.5%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical,Opthalmic
Patent Expiration Date : 2023-04-09
Date Granted : 2005-10-25
Patent Expiration Date : 2014-09-19
Date Granted : 2006-05-02
Brimonidine Tartrate, Timolol Maleate
Brand Name : COMBIGAN
Patent Number : 2173974
Filing Date : 1994-09-19
Strength per Unit : 0.2% / 0.5%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical,Opthalmic
Patent Expiration Date : 2014-09-19
Date Granted : 2006-05-02
Patent Expiration Date : 2020-01-04
Date Granted : 2009-08-04
Brimonidine Tartrate, Timolol Maleate
Brand Name : COMBIGAN
Patent Number : 2357014
Filing Date : 2000-01-04
Strength per Unit : 0.2% / 0.5%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical,Opthalmic
Patent Expiration Date : 2020-01-04
Date Granted : 2009-08-04
Patent Expiration Date : 2016-06-17
Date Granted : 2002-09-03
Brimonidine Tartrate, Timolol Maleate
Brand Name : COMBIGAN
Patent Number : 2225626
Filing Date : 1996-06-17
Strength per Unit : 0.2% / 0.5%
Dosage Form : Ophthalmic Solution
Human Or VET : Human
Route of Administration : Topical,Opthalmic
Patent Expiration Date : 2016-06-17
Date Granted : 2002-09-03
Patent Expiration Date : 2011-04-03
Date Granted : 2000-11-07
Brand Name : AZARGA
Patent Number : 2080223
Filing Date : 1991-04-03
Strength per Unit : 1% / 0.5%
Dosage Form : suspension
Human Or VET : Human
Route of Administration : ophthalmic (topical)
Patent Expiration Date : 2011-04-03
Date Granted : 2000-11-07
Patent Expiration Date : 2018-11-05
Date Granted : 2008-05-06
Brand Name : AZARGA
Patent Number : 2310230
Filing Date : 1998-11-05
Strength per Unit : 1% / 0.5%
Dosage Form : suspension
Human Or VET : Human
Route of Administration : ophthalmic (topical)
Patent Expiration Date : 2018-11-05
Date Granted : 2008-05-06
